Amy Shepherd
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Health top 0.5%
- Vaccine Coverage and Hesitancy
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 3
-
- interferon and immune responses 3
- Co-authors
- A. J. Bellingham (1 shared paper)John Marcus Wharton (1 shared paper)John P. Keenan (1 shared paper)C. H. Walsh (1 shared paper)G. Wetherley‐Mein (1 shared paper)R. K. Archer (1 shared paper)Francis S Gilbert (1 shared paper)Vanessa Martlew (1 shared paper)
- Journals
- Nature (4 papers)The Lancet (3 papers)British Journal of Haematology (2 papers)Clinical and Translational Science (1 paper)Transfusion Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Amy Shepherd
18 papers receiving 5.9k citations
Amy Shepherd's Hit Papers
Peers
Comparison fields: 5 of 144
- Infectious Diseases 4.0k
- Health 1.1k
- Modeling and Simulation 537
- Neurology 512
- Immunology 615
Countries citing papers authored by Amy Shepherd
This map shows the geographic impact of Amy Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Shepherd more than expected).
Fields of papers citing papers by Amy Shepherd
This network shows the impact of papers produced by Amy Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Shepherd. The network helps show where Amy Shepherd may publish in the future.
Co-authors
The 14 scholars most cited alongside Amy Shepherd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3621 |
| 2 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 867 |
| 3 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 4 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 5 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 228 |
| 6 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 121 |
| 7 | 1977 | 56 | |
| 8 | 2023 | 56 | |
| 9 | 1971 | 14 | |
| 10 | 2024 | 8 | |
| 11 | 2015 | 7 | |
| 12 | 2023 | 7 | |
| 13 | 1993 | 6 | |
| 14 | 2014 | 5 | |
| 15 | 2015 | 3 | |
| 16 | 2017 | 3 | |
| 17 | 1995 | 2 | |
| 18 | Physical Education and Academic Achievement: A Review | 2011 | 1 |
About Amy Shepherd
Amy Shepherd is a scholar working on Infectious Diseases, Immunology, Genetics, Rheumatology and Epidemiology, having authored 18 papers that have together received 6.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers), interferon and immune responses (3 papers), Eosinophilic Disorders and Syndromes (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Migration, Health and Trauma (1 paper), Plant and animal studies (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Infectious Diseases (4.0k citations), Health (1.1k citations), Modeling and Simulation (537 citations), Neurology (512 citations) and Immunology (615 citations). Amy Shepherd has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include A. J. Bellingham, John Marcus Wharton, John P. Keenan, C. H. Walsh, G. Wetherley‐Mein, R. K. Archer, Francis S Gilbert, Vanessa Martlew, Daniel Zeve and Meenakshi Rao. Their work appears in journals such as Nature, The Lancet, British Journal of Haematology, Clinical and Translational Science and Transfusion Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.